Healthcare

CommonSpirit Health, one of the nation’s largest health systems is facing a proposed class-action lawsuit over a ransomware attack it suffered last fall. How perilous is this for a health...

An experimental Alzheimer’s drug that moderately slows cognitive decline was approved by the Food and Drug Administration (FDA) on Friday. The drug, called lecanemab, was granted conditional approval based on...